Gillies McKenna
-
- Epigenetics and DNA Methylation 2
- Pluripotent Stem Cells Research 1
- DNA Repair Mechanisms 1
-
- Cancer, Hypoxia, and Metabolism 2
-
- Radiopharmaceutical Chemistry and Applications 2
-
- Lung Cancer Treatments and Mutations 2
- Advanced Breast Cancer Therapies 1
-
- Click Chemistry and Applications 1
- Co-authors
- Phillip A. SharpMichael R. BotchanDavid J. AmorBenedikt M. KesslerAbhay Narayan SinghBruno VazIgnacio TorrecillaRaimundo Freire
- Cited by
- Molecular BiologyGeneticsOncology
- Journals
- International Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)Cell Death Discovery (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Gillies McKenna
13 papers receiving 385 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 290
- Genetics 42
- Oncology 96
- Cancer Research 49
- Radiation 27
Countries citing papers authored by Gillies McKenna
This map shows the geographic impact of Gillies McKenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillies McKenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillies McKenna more than expected).
Fields of papers citing papers by Gillies McKenna
This network shows the impact of papers produced by Gillies McKenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillies McKenna. The network helps show where Gillies McKenna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gillies McKenna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 18 | |
| 2 | 2016 | 192 | |
| 3 | 2013 | 2 | |
| 4 | 2012 | 44 | |
| 5 | 2012 | 1 | |
| 6 | 2011 | 2 | |
| 7 | 2003 | 10 | |
| 8 | Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy | 2000 | 1 |
| 9 | 2000 | 2 | |
| 10 | 2000 | 3 | |
| 11 | 1997 | 30 | |
| 12 | 1978 | 49 | |
| 13 | 1974 | 57 |
About Gillies McKenna
Gillies McKenna is a scholar working on Cancer Research, Genetics and Oncology, having authored 13 papers that have together received 411 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epigenetics and DNA Methylation (2 papers), Lung Cancer Treatments and Mutations (2 papers), Advanced Breast Cancer Therapies (1 paper), Click Chemistry and Applications (1 paper), Pluripotent Stem Cells Research (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Molecular Biology (290 citations), Genetics (42 citations) and Oncology (96 citations). Gillies McKenna has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Phillip A. Sharp, Michael R. Botchan, David J. Amor, Benedikt M. Kessler, Abhay Narayan Singh, Bruno Vaz, Ignacio Torrecilla, Raimundo Freire, O. Gileadi and Marta Popović. Their work appears in journals such as International Journal of Cancer, Clinical Cancer Research, Cell Death Discovery, Cancer Biology & Therapy and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.